Achieved First-ever Quarterly Adjusted Corporate EBITDA1Profitability Generated Highest-ever Adjusted Store EBITDA Margin of 10.3% SHANGHAI and NEW YORK, Aug. 29, […]
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today […]
ZUG, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven […]